Regardless of if he knows the difference, he has typed that time and time again (go to YMB and browse his posts). We continually see a lack of attention to details at all levels. We have seen the wrong amount of 0s on important numbers in filings, typos in short press releases. This lack of attention to details can carry right up to making errors in understanding/filling out important documents.
How many important points may have been overlooked in agreements with shady investors or acquisition targets, understanding of Naz processes, FINRA responses, etc. Big ideas are great, but the devil is in the details.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links